<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>21982181</identifier>
<setSpec>0443-5117</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Majluf-Cruz, Abraham</dc:author>
<dc:description xml:lang="en">It is necessary to spread the knowledge about the disease, however, venous thromboembolic guidelines published in this issue give little attention to prevention, minimize the evaluation of the risk factors, do not evaluate its impact on the non-surgical patient, and do not emphasize the benefits of non-pharmacological and extended thromboprophylaxis. Guidelines for clinical practice of the Instituto Mexicano del Seguro Social must suggest the way to attend patients at the lowest cost with quality. Because prevention is the best tool to fight VTD, these guidelines do not totally accomplish their institutional objectives.</dc:description>
<dc:type>Editorial</dc:type>
<dc:language>es</dc:language>
<dc:date>2011 Jul-Aug </dc:date>
<dc:title xml:lang="es">La enfermedad tromboembólica venosa en el IMSS y en México.</dc:title>
<dc:title xml:lang="en">[The problem of the venous thromboembolic disease in Mexico].</dc:title>
<dc:publisher>Revista medica del Instituto Mexicano del Seguro Social</dc:publisher>
</metadata>
</record>
</pubmed-document>
